Abstract
Ovarian cancer is the leading gynecological malignancy worldwide. This is attributed to the fact that the disease is often diagnosed at an advanced stage, where the survival rates drop from approximately 90% (detection at an early stage) to 20%. Furthermore, ovarian cancer is not associated with overt physical symptoms. Thus, there is an urgent need for a highly sensitive and minimally invasive biomarker for the early detection of ovarian cancer. However, this continues to remain an unmet clinical need, as several proposed techniques have shown low sensitivity and specificity, with poor positive and negative predictive values. The quest for an ideal biomarker has bought exosomes to the forefront. Exosomes are small extracellular vesicles of an endocytic origin, which can encapsulate genetic information, in the form of proteins and miRNAs. They are released by multiple cell types and are involved in intercellular communication, through the transfer of their cargo. The process of exosome biogenesis allows for the packaging of molecules from both membranous and cytosolic origins. Therefore, exosomes are representations of the releasing cell, and thus provide an insight into the cellular environment. Furthermore, exosomal encapsulation of molecules such as proteins and miRNAs can prevent degradation, making exosomes an ideal biomarker source. Thus, this chapter provides an overview of ovarian cancer, the potential of exosomes as an early detection biomarker, and the different methods associated with the isolation of different vesicle subpopulations, and exosome enrichment.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Reid BM, Permuth JB, Sellers TA (2017) Epidemiology of ovarian cancer: a review. Cancer Biol Med 14(1):9–32
Hentze JL, Høgdall C, Kjær SK, Blaakær J, Høgdall E (2017) Searching for new biomarkers in ovarian cancer patients: rationale and design of a retrospective study under the Mermaid III project. Contemp Clin Trials Commun 8:167–174
Sharma S, Zuñiga F, Rice GE, Perrin LC, Hooper JD, Salomon C (2017) Tumor-derived exosomes in ovarian cancer—liquid biopsies for early detection and real-time monitoring of cancer progression. Oncotarget 8(61):104687–104703
Kozak KR, Amneus MW, Pusey SM, Su F, Luong MN, Luong SA et al (2003) Identification of biomarkers for ovarian cancer using strong anion-exchange ProteinChips: potential use in diagnosis and prognosis. Proc Natl Acad Sci U S A 100(21):12343
Desai A, Xu J, Aysola K, Qin Y, Okoli C, Hariprasad R et al (2014) Epithelial ovarian cancer: An overview. World J Transl Med 3(1):1–8
van Niel G, D'Angelo G, Raposo G (2018) Shedding light on the cell biology of extracellular vesicles. Nat Rev Mol Cell Biol 19:213
Wei W, Li N, Sun Y, Li B, Xu L, Wu L (2016) Clinical outcome and prognostic factors of patients with early-stage epithelial ovarian cancer. Oncotarget 8(14):23862–23870
Neesham D (2007) Ovarian cancer screening. Aust Fam Physician 36(3):126–128
Jayson GC, Kohn EC, Kitchener HC, Ledermann JA (2014) Ovarian cancer. Lancet 384(9951):1376–1388
Duffy MJ (2013) Tumor markers in clinical practice: a review focusing on common solid cancers. Med Princ Pract 22(1):4–11
Wang J, Zhang KY, Liu SM, Sen S (2014) Tumor-associated circulating microRNAs as biomarkers of cancer. Molecules 19(2):1912–1938
Rifai N, Gillette MA, Carr SA (2006) Protein biomarker discovery and validation: the long and uncertain path to clinical utility. Nat Biotechnol 24(8):971–983
Zarogoulidis P, Tsakiridis K, Karapantzou C, Lampaki S, Kioumis I, Pitsiou G et al (2015) Use of proteins as biomarkers and their role in carcinogenesis. J Cancer 6(1):9–18
Nawaz M, Camussi G, Valadi H, Nazarenko I, Ekstrom K, Wang X et al (2014) The emerging role of extracellular vesicles as biomarkers for urogenital cancers. Nat Rev Urol 11(12):688–701
Sadovska L, Eglitis J, Line A (2015) Extracellular vesicles as biomarkers and therapeutic targets in breast cancer. Anticancer Res 35(12):6379–6390
Lin J, Li J, Huang B, Liu J, Chen X, Chen X-M et al (2015) Exosomes: novel biomarkers for clinical diagnosis. Sci World J 2015:8
Properzi F, Logozzi M, Fais S (2013) Exosomes: the future of biomarkers in medicine. Biomark Med 7(5):769–778
Nedaeinia R, Manian M, Jazayeri MH, Ranjbar M, Salehi R, Sharifi M et al (2017) Circulating exosomes and exosomal microRNAs as biomarkers in gastrointestinal cancer. Cancer Gene Ther 24(2):48–56
Tang MKS, Wong AST (2015) Exosomes: emerging biomarkers and targets for ovarian cancer. Cancer Lett 367(1):26–33
Wang Z, Chen J-Q, J-l L, Tian L (2016) Exosomes in tumor microenvironment: novel transporters and biomarkers. J Transl Med 14(1):297
Raposo G, Stoorvogel W (2013) Extracellular vesicles: exosomes, microvesicles, and friends. J Cell Biol 200(4):373–383
Tkach M, Thery C (2016) Communication by extracellular vesicles: where we are and where we need to go. Cell 164(6):1226–1232
Cocucci E, Meldolesi J (2015) Ectosomes and exosomes: shedding the confusion between extracellular vesicles. Trends Cell Biol 25(6):364–372
Colombo M, Raposo G, Thery C (2014) Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles. Annu Rev Cell Dev Biol 30:255–289
Thery C, Zitvogel L, Amigorena S (2002) Exosomes: composition, biogenesis and function. Nat Rev Immunol 2(8):569–579
Beach A, Zhang H-G, Ratajczak MZ, Kakar SS (2014) Exosomes: an overview of biogenesis, composition and role in ovarian cancer. J Ovarian Res 7:14
Salomon C, Ryan J, Sobrevia L, Kobayashi M, Ashman K, Mitchell M et al (2013) Exosomal signaling during hypoxia mediates microvascular endothelial cell migration and vasculogenesis. PLoS One 8(7):e68451
Mathivanan S, Ji H, Simpson RJ (2010) Exosomes: extracellular organelles important in intercellular communication. J Proteome 73(10):1907–1920
Rice GE, Scholz-Romero K, Sweeney E, Peiris H, Kobayashi M, Duncombe G et al (2015) The effect of glucose on the release and bioactivity of Exosomes from first trimester Trophoblast cells. J Clin Endocrinol Metab 100(10):E1280–E1288
Melo SA, Sugimoto H, O'Connell JT, Kato N, Villanueva A, Vidal A et al (2014) Cancer exosomes perform cell-independent microRNA biogenesis and promote tumorigenesis. Cancer Cell 26(5):707–721
Taylor DD, Gercel-Taylor C (2008) MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol Oncol 110(1):13–21
Sharma S, Alharbi M, Kobayashi M, Lai A, Guanzon D, Zuniga F et al (2018) Proteomic analysis of exosomes reveals an association between cell invasiveness and exosomal bioactivity on endothelial and mesenchymal cell migration in vitro. Clin Sci (Lond) 132(18):2029–2044
Riches A, Campbell E, Borger E, Powis S (2014) Regulation of exosome release from mammary epithelial and breast cancer cells—a new regulatory pathway. Eur J Cancer 50(5):1025–1034
Szajnik M, Czystowska-Kuźmicz M, Elishaev E, Whiteside TL (2016) Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma. Expert Rev Mol Diagn 16(8):811–826
Aryani A, Denecke B (2016) Exosomes as a Nanodelivery system: a key to the future of Neuromedicine? Mol Neurobiol 53:818–834
Guo W, Gao Y, Li N, Shao F, Wang C, Wang P et al (2017) Exosomes: new players in cancer (review). Oncol Rep 38(2):665–675
Hon KW, Abu N, Ab Mutalib N-S, Jamal R (2017) Exosomes as potential biomarkers and targeted therapy in colorectal cancer: a mini-review. Front Pharmacol 8:583
Thery C, Amigorena S, Raposo G, Clayton A (2006) Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr Protoc Cell Biol. Chapter 3:Unit 3 22
Mathias RA, Lim JW, Ji H, Simpson RJ (2009) Isolation of extracellular membranous vesicles for proteomic analysis. Methods Mol Biol 528:227–242
Chen C, Skog J, Hsu CH, Lessard RT, Balaj L, Wurdinger T et al (2010) Microfluidic isolation and transcriptome analysis of serum microvesicles. Lab Chip 10(4):505–511
Hata T, Murakami K, Nakatani H, Yamamoto Y, Matsuda T, Aoki N (2010) Isolation of bovine milk-derived microvesicles carrying mRNAs and microRNAs. Biochem Biophys Res Commun 396(2):528–533
Michael A, Bajracharya SD, Yuen PS, Zhou H, Star RA, Illei GG et al (2010) Exosomes from human saliva as a source of microRNA biomarkers. Oral Dis 16(1):34–38
Rood IM, Deegens JK, Merchant ML, Tamboer WP, Wilkey DW, Wetzels JF et al (2010) Comparison of three methods for isolation of urinary microvesicles to identify biomarkers of nephrotic syndrome. Kidney Int 78(8):810–816
Lasser C, Eldh M, Lotvall J (2012) Isolation and characterization of RNA-containing exosomes. J Vis Exp 59:e3037
Tauro BJ, Greening DW, Mathias RA, Ji H, Mathivanan S, Scott AM et al (2012) Comparison of ultracentrifugation, density gradient separation, and immunoaffinity capture methods for isolating human colon cancer cell line LIM1863-derived exosomes. Methods 56(2):293–304
Chen CY, Hogan MC, Ward CJ (2013) Purification of exosome-like vesicles from urine. Methods Enzymol 524:225–241
Lasser C (2013) Identification and analysis of circulating exosomal microRNA in human body fluids. Methods Mol Biol 1024:109–128
McDonald MK, Capasso KE, Ajit SK (2013) Purification and microRNA profiling of exosomes derived from blood and culture media. J Vis Exp 76:e50294
Wei F, Yang J, Wong DT (2013) Detection of exosomal biomarker by electric field-induced release and measurement (EFIRM). Biosens Bioelectron 44:115–121
Kanwar SS, Dunlay CJ, Simeone DM, Nagrath S (2014) Microfluidic device (ExoChip) for on-chip isolation, quantification and characterization of circulating exosomes. Lab Chip 14(11):1891–1900
Kosanovic M, Jankovic M (2014) Isolation of urinary extracellular vesicles from Tamm-Horsfall protein-depleted urine and their application in the development of a lectin-exosome-binding assay. BioTechniques 57(3):143–149
Muller L, Hong CS, Stolz DB, Watkins SC, Whiteside TL (2014) Isolation of biologically-active exosomes from human plasma. J Immunol Methods 411:55–65
Enderle D, Spiel A, Coticchia CM, Berghoff E, Mueller R, Schlumpberger M et al (2015) Characterization of RNA from Exosomes and other extracellular vesicles isolated by a novel spin column-based method. PLoS One 10(8):e0136133
Greening DW, Xu R, Ji H, Tauro BJ, Simpson RJ (2015) A protocol for exosome isolation and characterization: evaluation of ultracentrifugation, density-gradient separation, and immunoaffinity capture methods. Methods Mol Biol 1295:179–209
Kanchi Ravi R, Khosroheidari M, DiStefano JK (2015) A modified precipitation method to isolate urinary exosomes. J Vis Exp 95:51158
Lane RE, Korbie D, Anderson W, Vaidyanathan R, Trau M (2015) Analysis of exosome purification methods using a model liposome system and tunable-resistive pulse sensing. Sci Rep 5:7639
Lobb RJ, Becker M, Wen SW, Wong CS, Wiegmans AP, Leimgruber A et al (2015) Optimized exosome isolation protocol for cell culture supernatant and human plasma. J Extracell Vesicles 4:27031
Stranska R, Gysbrechts L, Wouters J, Vermeersch P, Bloch K, Dierickx D et al (2018) Comparison of membrane affinity-based method with size-exclusion chromatography for isolation of exosome-like vesicles from human plasma. J Transl Med 16(1):1
Witwer KW, Buzás EI, Bemis LT, Bora A, Lässer C, Lötvall J et al (2013) Standardization of sample collection, isolation and analysis methods in extracellular vesicle research. J Extracell Vesicles. 2013 May 27;2. https://doi.org/10.3402/jev.v2i0.20360
Ha D, Yang N, Nadithe V (2016) Exosomes as therapeutic drug carriers and delivery vehicles across biological membranes: current perspectives and future challenges. Acta Pharm Sin B 6(4):287–296
Tang Y-T, Huang Y-Y, Zheng L, Qin S-H, Xu X-P, An T-X et al (2017) Comparison of isolation methods of exosomes and exosomal RNA from cell culture medium and serum. Int J Mol Med 40(3):834–844
Gámez-Valero A, Monguió-Tortajada M, Carreras-Planella L, Ml F, Beyer K, Borràs FE (2016) Size-exclusion chromatography-based isolation minimally alters extracellular vesicles’ characteristics compared to precipitating agents. Sci Rep 6:33641
Acknowledgments
Authors Disclosure Statement: The authors have no conflict of interest to declare.
Funding Statement: Lions Medical Research Foundation, Fondo Nacional de Desarrollo Científico y Tecnológico (FONDECYT 1170809), and Ovarian Cancer Research Foundation (OCRF). Shayna Sharma is supported by a Research Training Program Scholarship from the University of Queensland, funded by the Commonwealth Government of Australia.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Sharma, S., Salomon, C. (2020). Techniques Associated with Exosome Isolation for Biomarker Development: Liquid Biopsies for Ovarian Cancer Detection. In: Thurin, M., Cesano, A., Marincola, F. (eds) Biomarkers for Immunotherapy of Cancer. Methods in Molecular Biology, vol 2055. Humana, New York, NY. https://doi.org/10.1007/978-1-4939-9773-2_8
Download citation
DOI: https://doi.org/10.1007/978-1-4939-9773-2_8
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-4939-9772-5
Online ISBN: 978-1-4939-9773-2
eBook Packages: Springer Protocols